| Literature DB >> 20487634 |
Paolo Boscolo1, V Bellante, K Leopold, M Maier, L Di Giampaolo, A Antonucci, I Iavicoli, L Tobia, A Paoletti, M Montalti, C Petrarca, N Qiao, E Sabbioni, M Di Gioacchino.
Abstract
The object of this study is to determine the cytokine release from PBMCs exposed to Pd model nanoparticles emitted from catalytic converters. PBMCs of 8 healthy non-atopic women were incubated in the presence of Pd nanoparticles (5-10 nm) or salt (potassium hexa-chloropalladate) 10-5 and 10-6 M. Release of cytokines in supernatant of PBMCs was then determined. In cultures without LPS, IL-10 and IL-17 release from PBMCs was inhibited by Pd salt, while Pd nanoparticles inhibited TNF-alpha and IL-17 release. In LPS-stimulated cultures, release of IFN-gamma, TNF-alpha, IL-10 and IL-17 was inhibited by Pd salt, whereas IFN-gamma release was enhanced and TNF-alpha and IL-17 release was inhibited by Pd nanoparticles. In conclusion, Pd salt inhibits cytokine release, whereas Pd nanoparticles exert modulatory effects enhancing the release of IFN-gamma, a Th1 cytokine typical of delayed allergic reactions. This result is interesting considering the increase of allergic contact dermatitis to Pd in people exposed to Pd nanoparticles in urban environments.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20487634
Source DB: PubMed Journal: J Biol Regul Homeost Agents ISSN: 0393-974X Impact factor: 1.711